Angiogenesis, the growth of new blood vessels, is essential for normal development, reproduction, and wound repair, but also contributes to tumor growth, atherosclerosis, and other diseases. The long-term goals of this project are a) to identify the key regulatory molecules responsible for new blood vessel growth, and b) to determine what stimuli induce their expression. The ovary is ideal for such studies because intense but self-limiting angiogenesis occurs normally during follicle and corpus luteum (CL) development. Granulosa cells, which play a central role in follicle and CL function, express vascular endothelial growth factor (VEGF), a potent endothelial cell mitogen. Expression of VEGF by granulosa cells in vitro is rapidly, strongly and specifically stimulated by hypoxia, the normal environment in the growing follicle and formative CL. The linkage of VEGF gene expression to hypoxia, a fundamental stimulus for angiogenesis, strongly suggests that VEGF is a physiological mediator of new blood vessel growth. The hypotheses to be tested in this proposal are 1) that hypoxia rapidly stimulates VEGF mRNA and protein production via hypoxia-responsive transduction molecules that in turn activate specific control sequences on the VEGF gene, and 2) that the VEGF subsequently regulates ovarian blood vessel growth and function. There are five Specific Aims: 1) To measure changes in VEGF expression in the rat ovary during periods of vascular remodelling, including a) the preovulatory period and CL formation, b) CL regressions, and c) placental assumption of CL support at mid-pregnancy using quantitative reverse transcription-polymerase chain reaction; 2) To determine the time course and dose response of the hypoxia-induce increases in VEGF mRNA expression in isolated granulosa cells; 3) To determine if the increased VEGF mRNA expression in accompanied by increased VEGF protein synthesis and secretion; 4) To determine whether hypoxia exerts a direct effect on VEGF gene expression at the transcriptional level and to identify the specific sequences on the VEGF gene required for hypoxic stimulation of VEGF expression; 5) To identify transcription factors that regulate VEGF expression in granulosa cells in response to hypoxia. These studies will significantly increase knowledge of the mechanisms by which hypoxia regulates the expression of VEGF and other genes that control physiological and pathological angiogenesis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA045055-14
Application #
2330742
Study Section
Reproductive Biology Study Section (REB)
Program Officer
Freeman, Colette S
Project Start
1986-09-30
Project End
1999-01-31
Budget Start
1997-02-01
Budget End
1999-01-31
Support Year
14
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Maryland Baltimore
Department
Physiology
Type
Schools of Medicine
DUNS #
003255213
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Kazi, Armina A; Jones, Jenny M; Koos, Robert D (2005) Chromatin immunoprecipitation analysis of gene expression in the rat uterus in vivo: estrogen-induced recruitment of both estrogen receptor alpha and hypoxia-inducible factor 1 to the vascular endothelial growth factor promoter. Mol Endocrinol 19:2006-19
Koos, Robert D; Kazi, Armina A; Roberson, Mark S et al. (2005) New insight into the transcriptional regulation of vascular endothelial growth factor expression in the endometrium by estrogen and relaxin. Ann N Y Acad Sci 1041:233-47
Rockwell, L Christie; Pillai, Suresh; Olson, C Erik et al. (2002) Inhibition of vascular endothelial growth factor/vascular permeability factor action blocks estrogen-induced uterine edema and implantation in rodents. Biol Reprod 67:1804-10
Pillai, Suresh B; Jones, Jenny M; Koos, Robert D (2002) Treatment of rats with 17beta-estradiol or relaxin rapidly inhibits uterine estrogen receptor beta1 and beta2 messenger ribonucleic acid levels. Biol Reprod 67:1919-26
Hruska, Kathleen S; Tilli, Maddalena T; Ren, Shuxun et al. (2002) Conditional over-expression of estrogen receptor alpha in a transgenic mouse model. Transgenic Res 11:361-72
Pillai, S B; Rockwell, L C; Sherwood, O D et al. (1999) Relaxin stimulates uterine edema via activation of estrogen receptors: blockade of its effects using ICI 182,780, a specific estrogen receptor antagonist. Endocrinology 140:2426-9
Forsythe, J A; Jiang, B H; Iyer, N V et al. (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16:4604-13
Koos, R D (1995) Increased expression of vascular endothelial growth/permeability factor in the rat ovary following an ovulatory gonadotropin stimulus: potential roles in follicle rupture. Biol Reprod 52:1426-35
Koos, R D; Banks, P K; Inkster, S E et al. (1993) Detection of aromatase and keratinocyte growth factor expression in breast tumors using reverse transcription-polymerase chain reaction. J Steroid Biochem Mol Biol 45:217-25
Cullinan-Bove, K; Koos, R D (1993) Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth. Endocrinology 133:829-37

Showing the most recent 10 out of 17 publications